CRESTLINE MANAGEMENT, LP – Denali Therapeutics Inc. Transaction History
CRESTLINE MANAGEMENT, LP portfolio value:
$219.76M
portfolio value
CRESTLINE MANAGEMENT, LP quarter portfolio value change:
+4.28%
quarter
Denali Therapeutics Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -4.02% | -300K shares | 194K | $30.69 | 7.16M |
| Q2 2022 | share | 0.00% | 0 shares | -20.44M | $29.43 | 7.46M | |
| Q1 2022 | share | Decrease | -3.17% | -244.30K shares | -103.63M | $32.17 | 7.46M |
| Q4 2021 | share | 0.00% | 0 shares | -45.07M | $45.05 | 7.70M | |
| Q3 2021 | share | Decrease | -5.29% | -430.44K shares | -249.42M | $50.45 | 7.70M |
| Q2 2021 | share | Decrease | -18.52% | -1.84M shares | 68.01M | $78.44 | 8.13M |
| Q1 2021 | share | Decrease | -48.70% | -9.47M shares | 231.09M | $57.1 | 9.98M |
| Q4 2020 | share | Increase | +59.51% | 7.26M shares | -98.14M | $83.76 | 19.46M |
| Q3 2020 | share | Decrease | -10.58% | -1.44M shares | 107.25M | $35.83 | 12.20M |
| Q2 2020 | share | Decrease | -12.35% | -1.92M shares | 57.34M | $24.18 | 13.64M |
| Q1 2020 | share | Decrease | -20.01% | -3.89M shares | -66.44M | $17.51 | 15.56M |
| Q4 2019 | share | 0.00% | 0 shares | 40.87M | $17.42 | 19.46M | |
| Q3 2019 | share | 0.00% | 0 shares | -105.87M | $15.32 | 19.46M | |
| Q2 2019 | share | 0.00% | 0 shares | -47.87M | $20.76 | 19.46M | |
| Q1 2019 | share | 0.00% | 0 shares | 49.82M | $23.22 | 19.46M | |
| Q4 2018 | share | Decrease | -5.40% | -1.11M shares | -45.19M | $20.66 | 19.46M |
| Q3 2018 | share | 0.00% | 0 shares | 133.52M | $21.74 | 20.57M | |
| Q2 2018 | share | 0.00% | 0 shares | -91.34M | $15.25 | 20.57M | |
| Q1 2018 | share | Increase | 0.00% | 1 shares | 83.32M | $19.69 | 20.57M |
| Q4 2017 | share | Increase | 0.00% | 20.57M shares | 321.78M | $15.64 | 20.57M |